First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: A United Kingdom population-based cohort study

Keyphrases

• Absolute Risk 50%
• Adjusted Odds Ratio 25%
• Anxiety-depression 50%
• Anxiolytic 25%
• Anxiolytic Drugs 100%
• Benzodiazepines 50%
• Body Mass Index Status 25%
• Childbirth 25%
• Confidence Interval 25%
• Diazepam 50%
• Drug Exposure 25%
• During Pregnancy 50%
• Early Pregnancy 25%
• First Trimester 100%
• Generalized Estimating Equations 25%
• Hypnotic Medication 100%
• Logistic Regression 25%
• Major Congenital Anomalies 100%
• Maternal Age 25%
• Medication Use 25%
• Mental Illness 25%
• Non-benzodiazepine 50%
• Population-based Cohort Study 100%
• Pregnancy Trimester 50%
• Primary Care Database 25%
• Relative Risk 25%
• Risk-adjusted 25%
• Singleton 25%
• Socioeconomic Status 25%
• Temazepam 50%
• United Kingdom 100%
• Zopiclone 50%

Medicine and Dentistry

• Anxiolytic 100%
• Benzodiazepine 33%
• Body Mass Index 16%
• Childbirth 16%
• Cohort Analysis 100%
• Congenital Malformation 100%
• Diazepam 33%
• Drug Exposure 16%
• Drug Therapy 50%
• First Trimester Pregnancy 100%
• Hypnotic 100%
• Logistic Regression Analysis 16%
• Maternal Age 16%
• Nonbenzodiazepine 33%
• Odds Ratio 16%
• Prevalence 16%
• Primary Health Care 16%
• Socioeconomic Status 16%
• Temazepam 33%
• Zopiclone 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anxiolytic 100%
• Benzodiazepine 33%
• Cohort Study 100%
• Congenital Malformation 100%
• Diazepam 33%
• Hypnotic 100%
• Nonbenzodiazepine 33%
• Prevalence 16%
• Temazepam 33%
• Zopiclone 33%